rhBMP-2

rhBMP-2 has been studied in 2 papers since 2020: none in people yet, 1 in animals, 1 in cells; 1 in the past year. The research so far is in animals and cells. The newest paper, Jan 28, 2026: “Co-Treatment With rhBMP-2 and Rapamycin Modulates Osteogenesis-Adipogenesis Balance to Enhance Aged Bone Regeneration”.

Intervention

2 papers study it6 findingsUpdated

See all 2 papers on rhBMP-2

At a glance

The findings reach cells, none yet in people. 2 independent labs in 2 countries; 1 trial, none about aging.

None of its findings points the other way.

Cells: a single group. Worms or flies, mice and humans: nothing yet.
  • 2 independent labs in 2 countries
  • 1 trial, none about aging
  • Funders: National Key Research and Development Program of China and 1 more
  • Animals1
  • Cells1

What did studies of rhBMP-2 find?

6

Studies of rhBMP-2 measured 6 outcomes, among them Osteogenic response, Excess adipocyte accumulation and P16.

Osteogenic response

downin cells1

1 study
  1. rhBMP-2 decreases osteogenic response in senescent bone marrow stromal cells.

    “rhBMP-2 is found to exacerbate the imbalance between osteogenesis and adipogenesis in senescent bone marrow stromal cells (BMSCs), resulting in excess adipocytes (eADs) accumulation and a diminished osteogenic response”

    Cellsin senescent bone marrow stromal cellsrecombinant human

    Co-Treatment With rhBMP-2 and Rapamycin Modulates Osteogenesis-Adipogenesis Balance to Enhance Aged Bone Regeneration

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Excess adipocyte accumulation

upin cells1

1 study
  1. rhBMP-2 increases excess adipocyte accumulation in senescent bone marrow stromal cells.

    “rhBMP-2 is found to exacerbate the imbalance between osteogenesis and adipogenesis in senescent bone marrow stromal cells (BMSCs), resulting in excess adipocytes (eADs) accumulation and a diminished osteogenic response”

    Cellsin senescent bone marrow stromal cellsrecombinant human

    Co-Treatment With rhBMP-2 and Rapamycin Modulates Osteogenesis-Adipogenesis Balance to Enhance Aged Bone Regeneration

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

P16

upin human cells1

1 study
  1. rhBMP-2 increases P16 in human cells (p53 and p21 showed the same pattern).

    “The expression of p53, p21, and p16 in both low and high dose rhBMP-2 groups increased in all passages compared to the control group.”

    Cellsp53 and p21 showed the same patternrecombinant humannucleus pulposus cellslow and high dose

    The effect of prolonged rhBMP-2 treatment on telomerase activity, replicative capacity and senescence of human nucleus pulposus cells

    Biotechnic & histochemistry : official publication of the Biological Stain Commission

More on P16

Cellular senescence

upin human cells1

1 study
  1. rhBMP-2 increases cellular senescence in human cells (measured as SA-β-gal-positive cells with passaging).

    “The percentage of SA-β-gal-positive NPCs increased more rapidly in the high-dose rhBMP-2 group with passaging compared to the control and low-dose rhBMP-2 groups.”

    Cellsmeasured as SA-β-gal-positive cells with passagingrecombinant humannucleus pulposus cellshigh-dose

    The effect of prolonged rhBMP-2 treatment on telomerase activity, replicative capacity and senescence of human nucleus pulposus cells

    Biotechnic & histochemistry : official publication of the Biological Stain Commission

More on Cellular senescence

Telomerase activity

upin human cells1

1 study
  1. rhBMP-2 increases telomerase activity in human cells (serial passaging to end of replicative lifespan).

    “Mean telomerase activity was significantly greater in the high-dose rhBMP-2 group compared to the control and low-dose rhBMP-2 groups.”

    Cellsserial passaging to end of replicative lifespanrecombinant humannucleus pulposus cellshigh-dose

    The effect of prolonged rhBMP-2 treatment on telomerase activity, replicative capacity and senescence of human nucleus pulposus cells

    Biotechnic & histochemistry : official publication of the Biological Stain Commission

More on Telomerase activity

Replicative capacity

downin human cells1

1 study
  1. rhBMP-2 decreases replicative capacity in human cells (serial passaging to end of replicative lifespan).

    “The replicative capacity of NPCs in the high-dose rhBMP-2 group was decreased significantly compared to the control and low-dose rhBMP-2 groups.”

    Cellsserial passaging to end of replicative lifespanrecombinant humannucleus pulposus cellshigh-dose

    The effect of prolonged rhBMP-2 treatment on telomerase activity, replicative capacity and senescence of human nucleus pulposus cells

    Biotechnic & histochemistry : official publication of the Biological Stain Commission

Trial sponsors

  • Pfizer

    Company1 trialPhase 250 people

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months